Videos

Matthew John McNally, Evolved - Tax and Advisory | LSI Europe '22

At Evolved, CPAs and tax professionals deliver a full range of services, geared toward every stage of your personal and business growth.

Christopher Kent, Reveal Surgical - AI-Enabled Optical Detection | LSI Europe '22

Reveal Surgical's Sentry system is using advanced optical techniques such as Raman spectroscopy along with sophisticated machine learning algorithms to identify tissues with diffusely infiltrative cancer in vivo, while in surgery.

Piotr Wygocki, MIM Solutions - AI For Fertility Disorders | LSI Europe '22

MIM Solutions is using artificial intelligence and machine learning to address the worldwide fertility disorder occurring in an increasing number of countries. The company is currently developing two solutons that utilize AI to help couples struggling with infertility to conceive.

Andrew Glass, Vivasure Medical - Advanced Polymer Implants | LSI Europe '22

Vivasure's PerQseal closure device is touted as the first fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures like transcatheter aortic valve replacement (TAVR) and endovascular abdominal aortic aneurysm repair (EVAR).

Bench to Bedside: Why What We're Doing Matters | LSI Europe '22

A conversation with a world renowned cardiac surgeon and legendary innovator. Why does what we do matter? Where can (and should) we go as an industry?

Sandeep Chauhan, Definition Health - Digital Health Solutions | LSI Europe '22

Definition Health has developed an "end-to-end" approach that offers virtual management, pre-operative assessment, and post-operative recovery monitoring for patients undergoing elective surgeries.

Andrew Dahl, BioMEMS Diagnostics - Portable, In-Vitro Diagnostics Platform | LSI Europe '22

BioMEMS has developed a handheld, portable, in-vitro diagnostics platform that can analyze samples in under 3 minutes. The company's point-of-care platform is capable of analyzing samples from blood, mucus, urine and saliva.

Almog Aley-Raz, CorNeat Vision - Biomimetic Implants & Technology | LSI Europe '22

CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. Their technology has been applied to products for dental and ophthalmic surgery.

Charles Allan, MY01 - Timely Sensing for Compartment Syndrome | LSI Europe '22

The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.

Iwan van Vijfeijken, Pulsify Medical - Ultrasound Monitoring Patch | LSI Europe '22

The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.

David Kuraguntla, Alio - Noninvasive Remote Monitoring for Complications in Dialysis | LSI Europe '22

Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more.

Barry Keenan, Nervonik - Miniaturized Neuromodulation device | LSI Europe '22

They are developing a miniaturized neuromodulation device for therapeutic applications

Laura Yecies, Bone Health Technologies - Wearable Belt to Reduce Bone Loss | LSI Europe '22

Bone Health Technologies is developing OsteoBoost, a wearable belt that applies mechanical stimulation to the user in order to reduce bone loss and encourage bone growth in the hips and spine.

Ward Detwiler, SpinTech MRI - Addressing Challenges to MRI | LSI Europe '22

The company's STAGE (strategically acquired gradient echo) solution reduces MRI acquisition and processing time, improving patient throughput and workflow efficiency.

Kim Vanderlinden, Early Detection - Detecting Earliest Stages of Cancer | LSI Europe '22

Early Detection has developed a test to detect an altered sugar associated only with precanceous and cancerous tissue. The test can be delivered at the point-of-care and provides in-office results for patients and providers.

Mark Evans, Adaptix - Transforming Radiology | LSI Europe '22

Adaptix is developing an innovative, miniaturized flat panel X-ray source and associated software to transform existing X-ray systems into Digital Tomosynthesis systems to expand patient access to low-dose 3D imaging.

Daniel Levangie, CereVasc - Endovascularly Implantable CSF Shunt | LSI Europe '22

CereVasc's eShunt System is consists of an endovascularly implantable CSF shunt and associated delivery componentry designed to avoid the need for invasive surgery, general anesthesia, extended hospitalization, and post-procedure pain management.

Fred Colen, Neovasc - Treatment of Advanced Heart Disease | LSI Europe '22

Neovasc's products include Reducer, for the treatment of refractory angina and Tiara for the transcatheter treatment of mitral regurgitation.

Avi Fischer, ElectroPhysiology Frontiers - Treating Atrial Fibrillation | LSI Europe '22

ElectroPhysiology Frontiers is developing a unique, "single-shot" catheter for the ablation of atrial fibrillation. The device is being designed to deliver pulsed-field ablation (PFA) and radiofrequency ablation (RFA) to provide patients with a durable solution and reduce the need for subsequent interventions.

Ken Coffey, AtriAN Medical - Resolution of Atrial Fibrillation | LSI Europe '22

AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF).

David Neale, Arga Medtech - Cardiac Ablation System | LSI Europe '22

The company's Coherent Sine-burst Electroporation (CSE) uses a proprietary puled-field ablation (PFA) generator and catheter to offer a single-shot device capable of producing linear and focal lesions safer, more efficiently and faster than existing technologies used to treat cardiac arrhythmias today.

Jonathan Balfour, Panaxium - Precision Bioelectronic Devices | LSI Europe '22

The company's technology aims to make "untreatable" debilitating neurological conditions treatable via the use of precision bioelectronic devices that target specific cellular behaviors at the microscale.

Ilan Uchitel, CAPS Medical - Minimally Invasive Treatment of Solid Tumors | LSI Europe '22

CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP).

Thilo Hoelscher, BURL Concepts - Portable Ultrasound System | LSI Europe '22

BURL Concepts' SONAS is a portable, battery-powered ultrasound system that enables non-invasive brain perfusion assessment at the point-of-care. SONAS is used in combination with microbubble contrast agents to evaluate unilateral and bi-lateral cerebral perfusion

Rick Sanghera, AtaCor Medical - Transforming Cardiac Rhythm Management | LSI Europe '22

AtaCor is developing an innovative temporary pacing system that avoids the risks associated with transvenous leads.

Krishan Ramdoo, Tympa Health - Hearing Assessment Platform | LSI Europe '22

TympaHealth has developed an all-in-one hearing assessment platform for use at the point-of-care, including retail stores & assisted living facilities. The platform features a high-resolution otoscope for visualizing the ear drum, real-time screening audiogram, and micro-suction for ear wax removal.

Peter Stebbins, Nurami Medical - Soft Tissue Repair Technologies | LSI Europe '22

The company's flagship product, ArtiFascia, is a synthetic dural graft intended to facilitate the healing of the dura after cranial neurosurgery by creating an effective barrier that prevents harmful CSF leaks in dura repairs.

Christine Horton, Visura - Providing Physicians Real-Time Visualization | LSI Europe '22

Visura manufacturers the world's first, FDA-cleared, disposable camera, the TEECAD System, that seamlessly connects to a transesophageal echocardiogram (TEE) echo probe, providing physicians real-time visualization for more efficient and effective probe placement for safer intubation.

Ofer Levy, ZygoFix - Spinal Fusion Re-Imagined | LSI Europe '22

ZygoFix develops and commercializes its zLOCK system, a proprietary technology that adds "bend-ability" to joints and provide natural stabilization. The technology is currently used to achieve spinal fusion and spinal stability without screws.

Benjamin Pless, Celero Systems - Monitoring Chronic Conditions | LSI Europe '22

The company's HEALTH-Dx platform utilizes an ingestible pill to continuously monitor cardiac and respiratory vital signs for up to a week at a time.